
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
over 25 years ago
Does the HEDIS Asthma Measure Go Far Enough?over 25 years ago
Rheumatoid Arthritis: Guidelines for Emerging Therapies


